相关实验视频

Updated: Feb 24, 2026

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV

Published on: September 14, 2010

皮质类固醇在肺卡波西肉瘤中确实禁用吗?

Sai Anoosh Parimi¹, Bryan K Dunn²

¹Pulmonary and Critical Care, East Carolina Medical Center, Greenville, USA.

|February 23, 2026

概括

本案例报告强调了一例罕见的肺卡波西肉瘤 (KS) 病例,该病例发生在患有呼吸衰竭的艾滋病毒/艾滋病患者身上. 在这个肺部KS病例中,与帕克利塔克塞尔一起明智地使用皮质类固醇改善了结果.

科学领域:

在瘤学瘤学.
传染性疾病传染性疾病
肺部病理学肺部病理学

背景情况:

卡波西肉瘤 (KS) 是一种与人类疹病毒8 (HHV-8) 相关的血管增殖性疾病.
虽然KS通常表现为皮肤和皮外表现 (口腔,肠道,淋巴结),内脏器官的参与,特别是肺部,是非常罕见的.
肺癌可以严重表现,导致急性低血量呼吸衰竭 (AHRF) 等情况.

研究的目的:

在艾滋病毒/艾滋病患者中报告罕见的肺卡波西肉瘤病例.
讨论作为AHRF呈现的肺性KS的管理和结果.
评估皮质类固醇在治疗艾滋病毒/艾滋病相关的KS肺功能障碍中的作用.

主要方法:

一个患有艾滋病毒/艾滋病和肺癌的患者的病例报告.
经过支气管镜检查确认的诊断显示了支气管内膜病变.
治疗包括皮质类固醇和帕克利塔塞尔.

主要成果:

这位患者出现了AHRF,双侧膜液和内支气管病变.
用皮质类固醇和帕克利塔克塞尔治疗导致AHRF显著改善.
这表明,在治疗艾滋病毒/艾滋病-KS患者的肺功能障碍方面,明智使用皮质类固醇可能有潜在的益处.

结论:

肺癌是艾滋病毒/艾滋病患者罕见但严重的症状.
皮质类固醇,传统上在KS中谨慎使用,当在肺性KS中明智使用时,可能会带来治疗效益.
这一案例强调了在复杂的艾滋病毒/艾滋病病例中考虑罕见诊断和量身定制的治疗方法的重要性.

关键词:

抗艾滋病毒药物抗艾滋病毒药物排泄性多喷液排泄性多喷液艾滋病毒艾滋病病毒肺部卡波西肉瘤肺部卡波西肉瘤系统性类固醇类药物

更多相关视频

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

A Novel Method: Super-selective Adrenal Venous Sampling

A Novel Method: Super-selective Adrenal Venous Sampling

Published on: September 15, 2017

相关概念视频

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...